Radiobiology and molecular oncology: How are they changing radiotherapy in clinical practice?

Tumori

Volumn 96, Issue 1, 2010, Pages 175-177

  Alongi, Filippo ^a,b,c   Muzio, Nadia Di ^b  

^a Institute of Molecular Bioimaging and Physiology   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Fondazione Istituto San Raffaele Giuseppe Giglio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTON; VASCULOTROPIN RECEPTOR;

CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL SURVIVAL; FIBROSIS; HADRON; HISTOGRAM; HUMAN; HYPOXIA; IONIZING RADIATION; LETTER; MOLECULAR IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIOBIOLOGY; RADIOSENSITIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; TUMOR CELL;

BIOMEDICAL TECHNOLOGY; HUMANS; NEOPLASMS; PATHOLOGY, MOLECULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION ONCOLOGY; RADIOBIOLOGY; RADIOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77950790787     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600131     Document Type: Letter

References (18)

1. th International Conference on Translational Research and Preclinical Strategies in Radiation Oncology. Radiother Oncol, 90: s1-126, 2009.
2. Yu CX, Amies CJ, Svatos M: Planning and delivery of intensity- modulated radiation therapy. Med Phys, 35: 5233-5241, 2008.
3. Welsh JS: Basics of particle therapy: introduction to hadrons. Am J Clin Oncol, 31: 493-495, 2008.
4. O'Neill P, Wardman P: Radiation chemistry comes before radiation biology. Int J Radiat Biol, 85: 9-25, 2009.
5. Meyn RE,Milas L, Ang K: The role of apoptosis in radiation oncology. Int J Radiat Biol, 85: 107-115, 2009.
6. Baumann M, Krause M, Hill R: Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer, 8: 545-554, 2008.
7. Robson T, Hirst DG: Themed issue: radiation biology-can new concepts achieve better treatment outcomes? J Pharm Pharmacol, 60: 1243-1245, 2008.
8. Grégoire V, Haustermans K, Geets X, Roels S, Lonneux M: PET-based treatment planning in radiotherapy: a new standard? J Nucl Med, 48 (Suppl 1): 68S-77S, 2007.
9. Busk M, Horsman MR, Overgaard J: Resolution in PET hypoxia imaging: voxel size matters. Acta Oncol, 47: 1201-1210, 2008.
10. Bentzen SM: Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res, 139: 41-62, 2008.
11. Deasy JO, El Naqa I: Image-based modeling of normal tissue complication probability for radiation therapy. Cancer Treat Res, 139: 215-256, 2008.
12. Valdagni R, Rancati T, Ghilotti M, Cozzarini C, Vavassori V, Fellin G, Fiorino C, Girelli G, Barra S, Zaffaroni N, Pierotti MA, Gariboldi M: To bleed or not to bleed. A prediction based on individual gene profiling combined with dosevolume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys, 2009: 74: 1431-1440.
13. Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, Mornex F, Pèlegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS: Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res, 14: 6284-6288, 2008.
14. Borgmann K, Hoeller U, Nowack S, Bernhard M, Röper B, Brackrock S, Petersen C, Szymczak S, Ziegler A, Feyer P, Alberti W, Dikomey E: Individual radiosensitivity measured with lymphocytesmay predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys, 71: 256-264, 2008.
15. Brizel DM J: Pharmacologic approaches to radiation protection. Clin Oncol, 25: 4084-4089, 2007.
16. Quanz M, Berthault N, Roulin C, Roy M, Herbette A, Agrario C, Alberti C, Josserand V, Coll JL, Sastre-Garau X, Cosset JM, Larue L, Sun JS, Dutreix M: Small-molecule drugsmimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res,15: 1308-1316, 2009.
17. Shannon AM,Williams KJ: Antiangiogenics and radiotherapy. J Pharm Pharmacol, 60: 1029-1036, 2008.
18. Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL: Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 60: 1600-1614, 2008.